Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer

被引：0
|
作者：
Wanchun Ye [1 ]
Xiaolei Zhang [2 ]
Zhongjie Tang [1 ]
Yufeng Hu [1 ]
Yuanliang Zheng [1 ]
Yuping Yuan [1 ]
机构：
[1] The Dingli Clinical College of Wenzhou Medical University,Department of Clinical Laboratory
[2] Wenzhou Central Hospital,undefined
[3] The Second Affiliated Hospital of Shanghai University,undefined
[4] Jinan Fourth People’s Hospital,undefined
来源：
BMC Gastroenterology | / 25卷 / 1期
关键词：
Gastric cancer; Glycometabolism; PLOD2; Immune evasion; PI3K/AKT/mTOR pathway; Prognostic model; Therapeutic resistance;
D O I：
10.1186/s12876-025-03878-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Investigating PLOD2 as a therapeutic target to overcome metastasis in radiorecurrent prostate cancer
    Frame, Gavin
    Leong, Hon
    Haas, Roni
    Huang, Xiaoyong
    Wright, Jessica
    Boutros, Paul C.
    Kislinger, Thomas
    Liu, Stanley K.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
    Shao, Yingkuan
    Xu, Kailun
    Zheng, Xi
    Zhou, Biting
    Zhang, Xiuli
    Wang, Lin
    Sun, Yaoting
    Li, Dan
    Chen, Ting
    Wang, Jian
    Yu, Shaojun
    Sun, Lifeng
    Xu, Xiaoming
    Dai, Shaozhi
    Gao, Huanhuan
    Ruan, Guan
    Liu, Wei
    Cai, Xue
    Zhu, Tiansheng
    Qi, Lina
    Chen, Jiani
    Hu, Wangxiong
    Weng, Xingyue
    Zhu, Yi
    Xiang, Xueping
    Hu, Zhiyuan
    Li, Jinfan
    Chen, Lirong
    Shao, Jimin
    Zheng, Shu
    Guo, Tiannan
    CANCER COMMUNICATIONS, 2022, 42 (02) : 164 - 169
  • [3] Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker
    Zhang, Xin-Guo
    Li, Wen-Ting
    Jin, Xin
    Fu, Chuang
    Jiang, Wen
    Bai, Jie
    Shi, Zhi-Zhou
    BIOMEDICINES, 2025, 13 (02)
  • [4] Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer
    Zhang, Yao
    Mou, Yanhua
    Liang, Chao
    Zhu, Shenhao
    Liu, Shouyong
    Shao, Pengfei
    Li, Jie
    Wang, Zengjun
    PROSTATE, 2021, 81 (03): : 157 - 169
  • [5] Comprehensive analysis of prognostic genes in gastric cancer
    Huang, Shaohua
    Ma, Liping
    Lan, Biyang
    Liu, Ning
    Nong, Wenwei
    Huang, Zhihu
    AGING-US, 2021, 13 (20): : 23637 - 23651
  • [6] Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer
    Xue, Dong
    Peng, Hang
    Li, Zhenghui
    Xu, Jiarui
    Ma, Haiyun
    Dang, Yueyan
    Li, Fanni
    Wang, Guanghui
    Sun, Qi
    JOURNAL OF CANCER, 2024, 15 (03): : 809 - 824
  • [7] A novel prognostic and therapeutic target biomarker based on complement-related gene signature in gastric cancer
    Liu, Zuming
    Yang, Mingwei
    Shu, Hang
    Zhou, Jianmei
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (12)
  • [8] Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer
    Zhai, Zhao
    Wang, Shuo
    Cao, Yudong
    Liu, Jia
    Zhao, Qiang
    Ji, Yongpeng
    Yang, Xiao
    Tang, Xingxing
    Ma, Jinchao
    Du, Peng
    BIOMEDICINES, 2024, 12 (12)
  • [9] Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer
    Cemre Ucaryilmaz Metin
    Gulnihal Ozcan
    BMC Cancer, 22
  • [10] Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer
    Ucaryilmaz Metin, Cemre
    Ozcan, Gulnihal
    BMC CANCER, 2022, 22 (01)
12345